换一批
换一批Adding abiraterone to androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer: A systematic review and meta-analysis.
作者：
主题词
年龄因素(Age Factors);老年人(Aged);雄激素拮抗药(Androgen Antagonists);雄甾烯类(Androstenes);抗肿瘤药, 激素(Antineoplastic Agents, Hormonal);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);卡方分布(Chi-Square Distribution);临床试验(主题)(Clinical Trials as Topic);无病生存(Disease-Free Survival);人类(Humans);淋巴转移(Lymphatic Metastasis);男(雄)性(Male);中年人(Middle Aged);肿瘤, 激素依赖性(Neoplasms, Hormone-Dependent);比值比(Odds Ratio);泼尼松龙(Prednisolone);泼尼松(Prednisone);前列腺肿瘤(Prostatic Neoplasms);危险因素(Risk Factors);时间因素(Time Factors);治疗结果(Treatment Outcome)
DOI
10.1016/j.ejca.2017.07.003
PMID
28800492
发布时间
2023-11-12
- 浏览106
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
